NEW YORK (GenomeWeb) – Great Basin Scientific today commenced a public offering of units consisting of preferred stock and warrants. 

The Salt Lake City-based molecular diagnostics company is offering 2,724,000 units at $8.80 per unit. Each unit consists of one share of Series E preferred stock and eight Series C warrants. Each Series E preferred share will be convertible into four shares of common stock, and each Series C warrant will be exercisable into one share of common stock at an exercise price of $2.55 per share. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.